Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Epoetin alfa Product Approval Information - Licensing Action 7/26/99

Proper name: Epoetin alfa
Tradename: Epogen, Procrit
Manufacturer: Amgen, Inc, Thousand Oaks, CA, License #1080
Indication for Use: Pediatric Use
Approval Date: 7/26/99
Type of submission: Biologics license supplement


Approval Letter (PDF)

Label (PDF)

     Medical Review
     Statistical Review
     Clinical Pharmacology Review: Pharmacokinetics

Adverse Events List (PDF)

Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English